Product Description: Linavonkibart (SRK 181) is a high-affinity, fully human antibody that selectively binds to latent TGFβ1 and inhibits its activation. Linavonkibart plays an important role in cancer[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Brian T Welsh, et al. Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors. Int J Toxicol. 2021 May-Jun;40(3):226-241.